# Clinical Study of ATTR-CM

> **NCT04935021** · PHASE4 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 100 (estimated)

## Conditions studied

- Transthyroxine Amyloidosis Cardiomyopathy

## Interventions

- **DRUG:** ATTR-CM

## Key facts

- **NCT ID:** NCT04935021
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2031-06-01
- **Final completion:** 2031-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935021, "Clinical Study of ATTR-CM". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04935021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*